Pulmonary hypertension secondary to pulmonary fibrosis (PF-PH) is one of the most common causes of PH, and there is no approved therapy. The molecular signature of PF-PH and underlying mechanism of why pulmonary hypertension (PH) develops in PF patients remains understudied and poorly understood. We observed significantly increased vascular wall thickness in both fibrotic and non-fibrotic areas of PF-PH patient lungs compared to PF patients. The increased vascular wall thickness in PF-PH patients is concomitant with a significantly increased expression of the transcription factor Slug within the macrophages and its target prolactin-induced protein (PIP), an extracellular matrix protein that induces pulmonary arterial smooth muscle cell prol...
Pulmonary hypertension (PH) is a serious disorder with high morbidity and mortality rate. We analyze...
International audienceClinical and translational research has played a major role in advancing our u...
Independent of the underlying cause, pulmonary hypertension (PH) remains adevastating condition that...
Abstract Pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) is one of the most common ca...
Pulmonary hypertension (PH) is a chronic disorder of the pulmonary circulation that often associates...
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients (PF-PH) is a ...
BACKGROUND: Pulmonary hypertension (PH) is a severe disease with a poor prognosis. Different forms o...
Pulmonary hypertension (PH) is associated with vasoconstriction and remodelling. We studied lung tis...
Pulmonary arterial hypertension (PAH) results from endothelial cell (EC) damage leading to pulmonary...
Background—Pulmonary hypertension (PH) is a progressive disease characterized by raised pulmonary va...
Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major subtypes a...
12 pagesInternational audiencePulmonary hypertension (PH) is a progressive, lethal lung disease char...
Background: The p38 Mitogen Activated Protein Kinase (MAPK) system is increasingly recognised as an ...
Pulmonary arterial hypertension (PAH) is a rare multifactorial disease characterized by abnormal hig...
Pulmonary hypertension (PH) is a rare but deadly disease whose victims bear a 40% chance of mortalit...
Pulmonary hypertension (PH) is a serious disorder with high morbidity and mortality rate. We analyze...
International audienceClinical and translational research has played a major role in advancing our u...
Independent of the underlying cause, pulmonary hypertension (PH) remains adevastating condition that...
Abstract Pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) is one of the most common ca...
Pulmonary hypertension (PH) is a chronic disorder of the pulmonary circulation that often associates...
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients (PF-PH) is a ...
BACKGROUND: Pulmonary hypertension (PH) is a severe disease with a poor prognosis. Different forms o...
Pulmonary hypertension (PH) is associated with vasoconstriction and remodelling. We studied lung tis...
Pulmonary arterial hypertension (PAH) results from endothelial cell (EC) damage leading to pulmonary...
Background—Pulmonary hypertension (PH) is a progressive disease characterized by raised pulmonary va...
Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major subtypes a...
12 pagesInternational audiencePulmonary hypertension (PH) is a progressive, lethal lung disease char...
Background: The p38 Mitogen Activated Protein Kinase (MAPK) system is increasingly recognised as an ...
Pulmonary arterial hypertension (PAH) is a rare multifactorial disease characterized by abnormal hig...
Pulmonary hypertension (PH) is a rare but deadly disease whose victims bear a 40% chance of mortalit...
Pulmonary hypertension (PH) is a serious disorder with high morbidity and mortality rate. We analyze...
International audienceClinical and translational research has played a major role in advancing our u...
Independent of the underlying cause, pulmonary hypertension (PH) remains adevastating condition that...